BBLG logo

Bone Biologics (BBLG) Cash From Operations

Annual CFO

-$9.56 M
-$5.99 M-167.90%

December 31, 2023

Summary

Performance

1-Year Change

-167.9%

3-Year Change

-2138.44%

5-Year Change

-132.79%

15-Year Change

-186.96%

BBLG Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.82%
BBLG annual cash flow from operations is higher than 60.82% of companies in Healthcare sector

High & Low

All-time High

-$426.90 K

3-Year Low

-$9.56 M
BBLG annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BBLG previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 14, 2025
BBLG next annual earnings announcement is scheduled for May 14, 2025

OtherBBLGcash flowmetrics:

Annual CFI

-
BBLG annual cash flow from investing activities value is unknown

Annual CFF

$5.04 M
BBLG annual cash flow from financing activities is $5.04 million

Annual FCF

-$9.56 M
BBLG annual free cash flow is -$9.56 million

Annual CAPEX

-
BBLG annual capital expenditures value is unknown

Quarterly CFO

-$572.20 K
+$323.70 K+36.13%

September 30, 2024

Summary

Performance

3-Month Change

+36.13%

1-Year Change

+36.13%

3-Year Change

+84.25%

5-Year Change

+84.25%

BBLG Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.74%
BBLG quarterly cash flow from operations is higher than 70.74% of companies in Healthcare sector

High & Low

All-time High

-$72.20 K

3-Year Low

-$3.63 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BBLG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 14, 2025
BBLG next earnings announcement is scheduled for May 14, 2025

OtherBBLGcash flowmetrics:

Quarterly CFI

-
BBLG quarterly cash flow from investing activities value is unknown

Quarterly CFF

$1.81 M
BBLG quarterly cash flow from financing activities is $1.81 million

Quarterly FCF

-$572.20 K
BBLG quarterly free cash flow is -$572.20 thousand

Quarterly CAPEX

-
BBLG quarterly capital expenditures value is unknown

TTM CFO

-$4.79 M
+$1.98 M+29.28%

September 30, 2024

Summary

Performance

3-Month Change

+29.28%

1-Year Change

+29.28%

3-Year Change

+34.65%

5-Year Change

+34.65%

BBLG TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.65%
BBLG TTM cash flow from operations is higher than 68.65% of companies in Healthcare sector

High & Low

All-time High

-$405.00 K

3-Year Low

-$9.56 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BBLG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 14, 2025
BBLG next earnings announcement is scheduled for May 14, 2025

OtherBBLGcash flowmetrics:

TTM CFI

-
BBLG TTM cash flow from investing activities value is unknown

TTM CFF

$3.90 M
BBLG TTM cash flow from financing activities is $3.90 million

TTM FCF

-$4.79 M
BBLG TTM free cash flow is -$4.79 million

TTM CAPEX

-
BBLG TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BBLG Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-167.9%+36.1%+29.3%
3 y3 years-2138.4%+84.3%+34.6%
5 y5 years-132.8%+84.3%+34.6%

BBLG Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-677.8%at low-206.2%+84.3%-289.8%+49.9%
5 y5-year-2138.4%at low-692.5%+84.3%-1082.6%+49.9%
alltimeall time-2138.4%at low-692.5%+84.3%-1082.6%+49.9%

Bone Biologics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$572.20 K(-36.1%)
-$4.79 M(-29.3%)
Jun 2024
-
-$895.90 K(-31.3%)
-$6.77 M(-28.8%)
Mar 2024
-
-$1.30 M(-35.4%)
-$9.51 M(-0.5%)
Dec 2023
-$9.56 M(+167.9%)
-$2.02 M(-21.0%)
-$9.56 M(+0.7%)
Sep 2023
-
-$2.56 M(-29.7%)
-$9.49 M(+29.5%)
Jun 2023
-
-$3.63 M(+169.1%)
-$7.33 M(+80.7%)
Mar 2023
-
-$1.35 M(-30.8%)
-$4.06 M(+13.7%)
Dec 2022
-$3.57 M(+190.3%)
-$1.95 M(+393.5%)
-$3.57 M(+97.8%)
Sep 2022
-
-$395.30 K(+9.8%)
-$1.80 M(+7.0%)
Jun 2022
-
-$360.10 K(-58.2%)
-$1.69 M(-14.1%)
Mar 2022
-
-$860.80 K(+360.6%)
-$1.96 M(+59.6%)
Dec 2021
-$1.23 M(+187.8%)
-$186.90 K(-32.7%)
-$1.23 M(+5.2%)
Sep 2021
-
-$277.80 K(-56.3%)
-$1.17 M(+21.4%)
Jun 2021
-
-$636.00 K(+396.9%)
-$961.90 K(+137.5%)
Mar 2021
-
-$128.00 K(+1.8%)
-$405.00 K(-5.1%)
Dec 2020
-$426.90 K(-86.9%)
-$125.70 K(+74.1%)
-$426.90 K(-28.7%)
Sep 2020
-
-$72.20 K(-8.7%)
-$598.90 K(-40.2%)
Jun 2020
-
-$79.10 K(-47.2%)
-$1.00 M(-59.5%)
Mar 2020
-
-$149.90 K(-49.6%)
-$2.47 M(-24.0%)
Dec 2019
-$3.25 M
-$297.70 K(-37.3%)
-$3.25 M(-24.3%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$474.50 K(-69.4%)
-$4.29 M(-15.8%)
Jun 2019
-
-$1.55 M(+66.8%)
-$5.10 M(+21.0%)
Mar 2019
-
-$929.00 K(-30.6%)
-$4.21 M(+2.7%)
Dec 2018
-$4.10 M(+23.3%)
-$1.34 M(+4.6%)
-$4.10 M(+11.0%)
Sep 2018
-
-$1.28 M(+92.0%)
-$3.70 M(+24.2%)
Jun 2018
-
-$666.80 K(-18.6%)
-$2.98 M(-5.2%)
Mar 2018
-
-$818.90 K(-12.1%)
-$3.14 M(-5.7%)
Dec 2017
-$3.33 M(-54.6%)
-$931.70 K(+66.1%)
-$3.33 M(-9.2%)
Sep 2017
-
-$561.00 K(-32.4%)
-$3.67 M(-20.5%)
Jun 2017
-
-$829.30 K(-17.7%)
-$4.61 M(-20.6%)
Mar 2017
-
-$1.01 M(-20.5%)
-$5.81 M(-20.7%)
Dec 2016
-$7.33 M(+106.7%)
-$1.27 M(-15.8%)
-$7.33 M(+3.6%)
Sep 2016
-
-$1.51 M(-25.7%)
-$7.07 M(+7.1%)
Jun 2016
-
-$2.03 M(-19.8%)
-$6.61 M(+18.4%)
Mar 2016
-
-$2.53 M(+150.0%)
-$5.58 M(+57.4%)
Dec 2015
-$3.55 M(+28.7%)
-$1.01 M(-2.8%)
-$3.55 M(+39.9%)
Sep 2015
-
-$1.04 M(+3.8%)
-$2.53 M(+69.6%)
Jun 2015
-
-$1.00 M(+103.8%)
-$1.49 M(+203.8%)
Mar 2015
-
-$491.80 K
-$491.80 K
Dec 2014
-$2.76 M
-
-

FAQ

  • What is Bone Biologics annual cash flow from operations?
  • What is the all time high annual CFO for Bone Biologics?
  • What is Bone Biologics annual CFO year-on-year change?
  • What is Bone Biologics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bone Biologics?
  • What is Bone Biologics quarterly CFO year-on-year change?
  • What is Bone Biologics TTM cash flow from operations?
  • What is the all time high TTM CFO for Bone Biologics?
  • What is Bone Biologics TTM CFO year-on-year change?

What is Bone Biologics annual cash flow from operations?

The current annual CFO of BBLG is -$9.56 M

What is the all time high annual CFO for Bone Biologics?

Bone Biologics all-time high annual cash flow from operations is -$426.90 K

What is Bone Biologics annual CFO year-on-year change?

Over the past year, BBLG annual cash flow from operations has changed by -$5.99 M (-167.90%)

What is Bone Biologics quarterly cash flow from operations?

The current quarterly CFO of BBLG is -$572.20 K

What is the all time high quarterly CFO for Bone Biologics?

Bone Biologics all-time high quarterly cash flow from operations is -$72.20 K

What is Bone Biologics quarterly CFO year-on-year change?

Over the past year, BBLG quarterly cash flow from operations has changed by +$323.70 K (+36.13%)

What is Bone Biologics TTM cash flow from operations?

The current TTM CFO of BBLG is -$4.79 M

What is the all time high TTM CFO for Bone Biologics?

Bone Biologics all-time high TTM cash flow from operations is -$405.00 K

What is Bone Biologics TTM CFO year-on-year change?

Over the past year, BBLG TTM cash flow from operations has changed by +$1.98 M (+29.28%)